Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 5 The autonomic function test results of the studied groups

From: Evaluation of peripheral and autonomic nervous systems dysfunctions in patients with Parkinson’s disease

 

Mean

Std. Dev

F

Sig

Tukey test

E/I ratio

Control

1.2660

0.06073

4.724

0.013

P1:0.661

P2:0.011

P3:0.094

Drug-naïve patients with PD

1.2385

0.08087

Patients with PD on dopaminergic drugs

1.1705

0.14307

Valsalva ratio

Control

1.2805

0.03804

6.518

0.003

P1: 0.603

P2:0.003

P3: 0.037

Drug-naïve patients with PD

1.2480

0.09197

Patients with PD on dopaminergic drugs

1.1625

0.15586

30:15 ratio

Control

1.0795

0.02350

8.294

0.001

P1:0.748

P2: 0.008

P3:0.001

Drug-naive

1.0585

0.04603

Patients with PD on dopaminergic drugs

1.1690

0.14913

CSP (median sensory n) onset latency

Control

76.2000

2.33057

7.843

0.001

P1: 0.542

P2:0.001

P3:0.020

Drug-naïve patients with PD

78.5500

5.46255

Patients with PD on dopaminergic drugs

84.7000

10.58847

CSP (median sensory n) duration

Control

44.2500

2.97135

1.862

0.165

P1:1.00

P2:0.230

P3: 0.220

Drug-naïve patients with PD

44.3000

4.84605

Patients with PD on dopaminergic drugs

41.3000

7.92132

CSP (sural nerve) onset latency

Control

94.7500

2.46822

12.034

0.001

P1:0.853

P2: 0.001

P3:0.001

Drug-naïve patients with PD

96.1500

7.69330

Patients with PD on dopaminergic drugs

106.4500

11.75842

CSP (sural n) duration

control

46.8500

2.79614

4.443

0.016

P1:0.275

P2: 0.012

P3:0.335

Drug-naïve patients with PD

43.8000

5.53078

Patients with PD on dopaminergic drugs

41.0000

8.80191

SSR (Palm)sec

Control

1.2250

.08507

4.313

0.018

P1:0.528

P2: 0.014

P3:0.173

Drug-naïve patients with PD

1.3350

.21343

Patients with PD on dopaminergic drugs

1.5200

.50638

SSR (Sole) sec

Control

1.5500

.14327

13.646

0.001

P1:0.001

P2: 0.001

P3:0.395

Drug-naïve patients with PD

2.0050

.36631

Patients with PD on dopaminergic drugs

2.1650

.54122

Systolic blood pressure to active standing(mmHg)

Control

9.4000

1.09545

152.879

0.001

P1:0.415

P2:0.001

P3:0.001

Drug-naïve patients with PD

11.1500

7.43587

Patients with PD on dopaminergic drugs

31.0000

0.00000

Diastolic blood pressure response to sustained hand grip (mmHg)

Control

18.0000

0.000

5.980

0.004

P1:0.039

P2: 0.004

P3:0.679

Drug-naïve patients with PD

15.3550

4.32672

Patients with PD on dopaminergic drugs

14.5000

3.83200

SSR amplitude (mv) palm

Control

1.2000

0.000

10.750

0.001

P1:0.945

P2:0.001

P3: 0.001

Drug-naïve patients with PD

1.1800

0.15079

Patients with PD on dopaminergic drugs

0.9400

0.30677

SSR amplitude (mv) sole

Control

0.3550

0.06863

52.916

0.001

P1:0.001

P2:0.001

P3: 0.113

Drug-naïve patients with PD

0.2260

0.04988

Patients with PD on dopaminergic drugs

0.1920

0.03443

Ewing score

Control

0.1000

0.20520

2.784

0.071

P1:0.760

P2:0.060

P3:0.029

Drug-naïve patients with PD

0.5000

1.53897

Patients with PD on dopaminergic drugs

1.2500

2.22131

  1. E/I expiratory/inspiratory, CSP cutaneous silent period, SSR sympathetic skin response, P1 control versus drug-naïve patients. P2: control versus patients with PD on dopaminergic drugs. P3: drug-naïve patients versus patients with PD on dopaminergic drugs
Back to article page